Effects of Nicotine Pouch Characteristics on Perceptions and Behavior
NCT ID: NCT06597435
Last Updated: 2024-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
72 participants
INTERVENTIONAL
2024-10-31
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nicotine pouch containing high nicotine (6-8mg)
Participants will self-administer a nicotine pouch containing 6-8mg nicotine.
Nicotine pouch
Participants will self-administer an experimenter-provided nicotine pouch
Nicotine pouch containing low nicotine (3-4mg)
Participants will self-administer a nicotine pouch containing 3-4mg nicotine.
Nicotine pouch
Participants will self-administer an experimenter-provided nicotine pouch
Nicotine pouch with low pH (less than 8.5)
Participants will self-administer a nicotine pouch with low pH (less than 8.5).
Nicotine pouch
Participants will self-administer an experimenter-provided nicotine pouch
Nicotine pouch with high pH (8.5 or greater)
Participants will self-administer a nicotine pouch with high pH (8.5 or greater).
Nicotine pouch
Participants will self-administer an experimenter-provided nicotine pouch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine pouch
Participants will self-administer an experimenter-provided nicotine pouch
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current nicotine pouch users (used nicotine pouches in the past 30 days). Current dual users of nicotine pouches and e-cigarettes and/or combustible cigarettes will be eligible.
* Positive cotinine test via saliva test strip.
* Unmotivated to quit nicotine use.
* English language competency (read and speak English). The instruments used have not been translated and/or validated for other languages.
Exclusion Criteria
* Current pregnancy or breastfeeding (urine pregnancy test will be conducted during the orientation session).
* History of stroke, seizures, high blood pressure (hypertension), heart disease/problems, lung disease/lung problems, or cardiovascular disease contraindications for nicotine.
* People under 21 years will be excluded to correspond with the legal age for purchasing tobacco products in the United States. Special subject populations will not be recruited.
21 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Southern California
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dae Hee Han
Postdoctoral Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dae Hee Han, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Southern California
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Southern California
Los Angeles, California, United States
University of Southern California - Clinical Sciences Building
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
April Norambuena
Role: primary
Dae Hee Han, PhD
Role: backup
Christian Hendershot, PhD
Role: primary
Dae Hee Han, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UP-23-01161
Identifier Type: -
Identifier Source: org_study_id